{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:45:23Z","timestamp":1783043123367,"version":"3.54.6"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>Rejection is one of the most important drawbacks for graft and patient survival in intestinal and multivisceral transplantation. However, there is no consensus on the diagnostic criteria for humoral rejection, and the literature about the role of donor\u2010specific antibodies (DSA) on allograft outcome and the risk factors that contribute to their development is scant with contradictory results. The present study analyzes the role of DSA exclusively in a pediatric cohort of 43 transplants. Among our patients, 11.6% showed preformed DSA, but they did not correlate with more rejection or less allograft survival. Having previous transplants was the main sensitization factor with an odds ratio (OR) = 44.85 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). In total, 16.3% of recipients developed de novo donor\u2010specific antibodies (dnDSA), mostly directed against human leukocyte antigen (HLA) class II, polyspecific and complement fixing. Additionally, the presence of dnDSA had a deleterious effect on graft rejection (hazard ratio [HR] = 11.00; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01) and survival (HR = 66.52; <jats:italic toggle=\"yes\">P <\/jats:italic>&lt; 0.001) in an observational period of 5 years after transplantation. The inclusion of the liver emerged as the main protective factor against dnDSA development with an OR = 0.07 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007). The analysis of HLA compatibility at the serological and epitope level with the computational tools HLAMatchmaker and PIRCHE revealed no association between HLA mismatching and dnDSA. In conclusion, this study performed in pediatric recipients shows the deleterious effect of dnDSA on intestinal transplantation supported by the complement\u2010fixing activity observed. Additionally, the liver inclusion in the allografts showed to be a protective factor against dnDSA generation.<\/jats:p>","DOI":"10.1002\/lt.25323","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T08:37:41Z","timestamp":1534408661000},"page":"1726-1735","source":"Crossref","is-referenced-by-count":29,"title":["Donor\u2010Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching"],"prefix":"10.1097","volume":"24","author":[{"given":"Paloma","family":"Talayero","sequence":"first","affiliation":[{"name":"Department of Immunology,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"I+12 Research Institute,University Hospital 12 de Octubre,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ramos Boluda","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Intestinal Rehabilitation Unit,University Hospital La Paz,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"G\u00f3mez Massa","sequence":"additional","affiliation":[{"name":"Department of Immunology,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"I+12 Research Institute,University Hospital 12 de Octubre,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Castro Panete","sequence":"additional","affiliation":[{"name":"Department of Immunology,University Hospital 12 de Octubre,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Prieto Bozano","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Intestinal Rehabilitation Unit,University Hospital La Paz,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Hern\u00e1ndez Oliveros","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery,University Hospital La Paz,Madrid,Spain"},{"name":"EOC of ERN\u2010Transplantchild,University Hospital La Paz,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"L\u00f3pez Santamar\u00eda","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery,University Hospital La Paz,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Calvo Pulido","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery and Abdominal Organ Transplantation,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"School of Medicine,Complutense University,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Paz\u2010Artal","sequence":"additional","affiliation":[{"name":"Department of Immunology,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"I+12 Research Institute,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"School of Medicine,Complutense University,Madrid,Spain"},{"name":"Section of Immunology,San Pablo CEU University,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mancebo","sequence":"additional","affiliation":[{"name":"Department of Immunology,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"I+12 Research Institute,University Hospital 12 de Octubre,Madrid,Spain"},{"name":"School of Medicine,Complutense University,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"lt25323-bib-0001-20240115","first-page":"427","article-title":"Intestine and multivisceral transplantation: current status and future directions","volume":"17","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"lt25323-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00383-016-3885-2","article-title":"Intestinal transplantation in children: current status","volume":"32","year":"2016","journal-title":"Pediatr Surg Int"},{"key":"lt25323-bib-0003-20240115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0b013e318229f752","article-title":"Association between donor\u2010specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation","volume":"92","year":"2011","journal-title":"Transplantation"},{"key":"lt25323-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1111\/j.1600-6143.2012.04237.x","article-title":"Preformed and de novo donor specific antibodies in visceral transplantation: long\u2010term outcome with special reference to the liver","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/tri.12250","article-title":"Clinical relevance of the de novo production of anti\u2010HLA antibodies following intestinal and multivisceral transplantation","volume":"27","year":"2014","journal-title":"Transpl Int"},{"key":"lt25323-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/TP.0000000000000614","article-title":"Prospective monitoring of donor\u2010specific anti\u2010HLA antibodies after intestine\/multivisceral transplantation: significance of de novo antibodies","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"lt25323-bib-0007-20240115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/TP.0000000000001391","article-title":"Prevalence and clinical impact of donor\u2010specific alloantibody among intestinal transplant recipients","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"lt25323-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation","volume":"3","year":"2003","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0009-20240115","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement\u2010binding anti\u2010HLA antibodies and kidney\u2010allograft survival","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"lt25323-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q\u2010fixing donor\u2010specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/tri.12684","article-title":"Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance","volume":"29","year":"2016","journal-title":"Transpl Int"},{"key":"lt25323-bib-0012-20240115","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.healun.2014.02.033","article-title":"Pre\u2010transplant donor HLA\u2010specific antibodies: characteristics causing detrimental effects on survival after lung transplantation","volume":"33","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"lt25323-bib-0013-20240115","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/ajt.14685","article-title":"Antibody\u2010mediated rejection in pediatric small bowel transplantation: capillaritis is a major determinant of C4d positivity in intestinal transplant biopsies","volume":"18","year":"2018","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/SLA.0b013e3181b67725","article-title":"Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges","volume":"250","year":"2009","journal-title":"Ann Surg"},{"key":"lt25323-bib-0015-20240115","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/TP.0b013e31820000a1","article-title":"Pretransplant predictors of survival after intestinal transplantation: analysis of a single\u2010center experience of more than 100 transplants","volume":"90","year":"2010","journal-title":"Transplantation"},{"key":"lt25323-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ajt.12979","article-title":"for Intestinal Transplant Association. Intestinal transplant registry report: global activity and trends","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0017-20240115","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s00595-010-4324-y","article-title":"Current status of intestinal transplantation","volume":"40","year":"2010","journal-title":"Surg Today"},{"key":"lt25323-bib-0018-20240115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.sla.0000157265.85388.a1","article-title":"2003 report of the intestine transplant registry: a new era has dawned","volume":"241","year":"2005","journal-title":"Ann Surg"},{"key":"lt25323-bib-0019-20240115","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.12812","article-title":"The current state of intestine transplantation: indications, techniques, outcomes and challenges","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0020-20240115","article-title":"Impacts of donor\u2010specific anti\u2010HLA antibodies and antibody\u2010mediated rejection on outcomes after intestinal transplantation in children","volume":"21","year":"2017","journal-title":"Pediatr Transplant"},{"key":"lt25323-bib-0021-20240115","first-page":"177","article-title":"Intestinal transplant: in what phase are we?","volume":"23","year":"2010","journal-title":"Cir Pediatr"},{"key":"lt25323-bib-0022-20240115","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1600-6143.2005.00874.x","article-title":"Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti\u2010thymocyte globulin (thymoglobulin)","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"lt25323-bib-0023-20240115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1432-2277.2008.00785.x","article-title":"Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance","volume":"22","year":"2009","journal-title":"Transpl Int"},{"key":"lt25323-bib-0024-20240115","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.transproceed.2012.07.016","article-title":"Intestinal and multivisceral transplantation immunosuppression protocols\u2013literature review","volume":"44","year":"2012","journal-title":"Transplant Proc"},{"key":"lt25323-bib-0025-20240115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1399-0012.2008.00922.x","article-title":"Impact of induction therapy on bacterial infections and long\u2010term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab","volume":"23","year":"2009","journal-title":"Clin Transplant"},{"key":"lt25323-bib-0026-20240115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/01.TP.0000062840.49159.2F","article-title":"A schema for histologic grading of small intestine allograft acute rejection","volume":"75","year":"2003","journal-title":"Transplantation"},{"key":"lt25323-bib-0027-20240115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.transproceed.2004.01.079","article-title":"Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium","volume":"36","year":"2004","journal-title":"Transplant Proc"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.25323","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201812000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T01:13:44Z","timestamp":1705281224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201812000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.25323","relation":{},"ISSN":["1527-6465","1527-6473"],"issn-type":[{"value":"1527-6465","type":"print"},{"value":"1527-6473","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}